Browse by Author or Creator

2022

• Naidoo, M., Jones, L., Conboy, B., Hamarneh, W., D'Souza, D., Anthony, K. and Machado, L. (2022) Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma. Poster presented to: Cancer Research UK Brain Tumour Conference, 2022-09-05 - 2022-09-07.
• Hameed, A., Ketley, J., Woodacre, A., Machado, L. and Marsden, G. L. (2022) Molecular and In Silico typing of the lipooligosaccharide biosynthesis gene cluster in Campylobacter jejuni and Campylobacter coli. PLoS ONE. 17(3) 1932-6203.
• Khalsan, M., Machado, L., SALIH AL-SHAMERY, E., Ajit, S., Anthony, K., Mu, M. and Opoku Agyeman, M. (2022) A Survey of Machine Learning Approaches Applied to Gene Expression Analysis for Cancer Prediction. IEEE Access. 2169-3536.
• Naidoo, M., Jones, L., Conboy, B., Hamarneh, W., D'Souza, D., Anthony, K. and Machado, L. (2022) Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma. Scientific Reports. 12(1) 2045-2322.

2021

• Machado, L., Al-Rayahi, I. A. M. and Stover, C. (2021) Properdin is a modulator of tumour immunity in a syngeneic mouse melanoma model. Medicina. 57(2) 1010-660X.

2020

• Jones, L., Naidoo, M., Machado, L. and Anthony, K. (2020) The Duchenne muscular dystrophy gene and cancer. Cellular oncology (Dordrecht). 44(1), pp. 19-32. 2211-3428.
• Machado, L., Woodacre, A., Hameed, A. and Marsden, G. L. (2020) An Updated Classification System and Review of the Lipooligosaccharide Biosynthesis Gene Locus in Campylobacter jejuni. Frontiers in Microbiology. 11(677), pp. 1-11. 1664-302X.

2018

• Ash, A., Machado, L., Raleigh, S. M. and Anthony, K. (2018) Neuropathophysiology of Duchenne muscular dystrophy: involvement of the dystrophin isoform Dp71 in cell migration and proliferation. Neuromuscular Disorders. 28(Sup. 1) 0960-8966.
• Ash, A., Machado, L., Raleigh, S. M. and Anthony, K. (2018) Neuropathophysiology of Duchenne muscular dystrophy: involvement of the dystrophin isoform Dp71 in cell migration and proliferation. Neuromuscular Disorders. 28(Sup. 1) 0960-8966.
• Patel, P. M., Ottensmeier, C., Mulatero, C., Lorigan, P., Plummer, R., Pandha, H., Elsheik, S., Hadjimichael, E., Villasanti, N., Adams, S. E., Cunnell, M., Metheringham, R. L., Brentville, V. A., Machado, L., Daniels, I., Gijon, M., Hannaman, D. and Durrant, L. G. (2018) Targeting gp100 and TRP-2 with a DNA vaccine: incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial. OncoImmunology. 7(6) 2162-4011.
• Ash, A., Machado, L., Raleigh, S. M. and Anthony, K. (2018) Neuropathophysiology of Duchenne muscular dystrophy: involvement of the dystrophin isoform Dp71 in cell migration and proliferation. Poster presented to: 11th Annual Neuromuscular Translational Research Conference, Fitzwilliam College, Cambridge, 19-20 April 2018.
• Patel, P. M., Ottensmeier, C., Mulatero, C., Lorigan, P., Plummer, R., Pandha, H., Elsheik, S., Hadjimichael, E., Villasanti, N., Adams, S. E., Cunnell, M., Metheringham, R. L., Brentville, V. A., Machado, L., Daniels, I., Gijon, M., Hannaman, D. and Durrant, L. G. (2018) Targeting gp100 and TRP-2 with a DNA vaccine: incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial. OncoImmunology. 7(6), e1433516. 2162-4011.

2017

• Machado, L., Moseley, P. M., Moss, R., Deen, S., Nolan, C., Spendlove, I. and Ramage, J. (2017) High mobility group protein B1 is a predictor of poor survival in ovarian cancer. Oncotarget. 8(60) 1949-2553.
• Machado, L., Moseley, P. M., Moss, R., Deen, S., Nolan, C., Spendlove, I. and Ramage, J. (2017) High mobility group protein B1 is a predictor of poor survival in ovarian cancer. Oncotarget. 8(60), pp. 101215-101223. 1949-2553.
• Poole, H., Sixsmith, J., Parkes, J., Ward, A., Pyer, M., Campbell, J., Machado, L., Rehling, T., Youell, J., Carter, J., Oyebode, J., O’Malley, M., Anthony, K., Rogers, S., Jones, J., Siddons, L., Smith, L.-A., Kay, A. D., Fraser, M., Score, J., El Khoury, L., Hameed, A., Albalbeisi, N., Durrant, L. G., Al-Zubaidi, R., Al-Rayahi, I., da Silva, K. and Taylor, J. (2017) Health and wellbeing amongst older people research in Northamptonshire.
• Zuccherato, L., Schneider, S., Tarazona-Santos, E., Hardwick, R. J., Berg, D., Bogle, H., Gouveia, M., Machado, L., Machado, M., Rodrigues-Soares, F., Soares-Souza, G., Togni, D., Zamudio, R., Gilman, R., Duarte, D., Hollox, E. J. and Rodrigues, M. R. (2017) Population genetics of immune-related multilocus CNV in Native Americans. Journal of the Royal Society Interface. 14(128) 1742-5689.
• Zuccherato, L., Schneider, S., Tarazona-Santos, E., Hardwick, R. J., Berg, D., Bogle, H., Gouveia, M., Machado, L., Machado, M., Rodrigues-Soares, F., Soares-Souza, G., Togni, D., Zamudio, R., Gilman, R., Duarte, D., Hollox, E. J. and Rodrigues, M. R. (2017) Population genetics of immune-related multilocus copy number variation in Native Americans. Journal of the Royal Society Interface. 14(128) 1742-5689.

2016

• Rahbari, R., Zuccherato, L. W., Tischler, G., Chihota, B., Ozturk, H., Saleem, S., Tarazona-Santos, E., Machado, L. and Hollox, E. J. (2016) Understanding the genomic structure of copy number variants of the low-affinity Fcγ receptor region allows confirmation of the association of FCGR3B deletion with rheumatoid arthritis. Human Mutation. 1059-7794.
• Rahbari, R., Zuccherato, L. W., Tischler, G., Chihota, B., Ozturk, H., Saleem, S., Tarazona-Santos, E., Machado, L. and Hollox, E. J. (2016) Understanding the genomic structure of copy number variants of the low-affinity Fcγ receptor region allows confirmation of the association of FCGR3B deletion with rheumatoid arthritis. Human Mutation. 38(4), pp. 390-399. 1059-7794.
• Rahbari, R., Zuccherato, L., Tischler, G., Chihota, B., Tarazona-Santos, E., Machado, L. and Hollox, E. J. (2016) Understanding the genomic structure of copy number variants of the low-affinity Fcγ receptor region allows confirmation of the association of FCGR3B deletion with rheumatoid arthritis. Poster presented to: British Society for Immunology/Dutch Society for Immunology (BSI/NVVI) Annual Congress 2016, Liverpool, 06-09 December 2016.
• Machado, L., Moseley, P. M., Moss, R., Deen, S., Nolan, C., Spendlove, I., Ramage, J., Chan, S. and Durrant, L. G. (2016) Downregulation of the citrullinating enzyme Peptidyl-arginine deiminase type-2 in ovarian cancer indicates poor prognosis. Poster presented to: National Cancer Research Institute (NCRI) Cancer Conference, Liverpool, UK, 06-09 November 2016.
• Machado, L., Moseley, P. M., Moss, R., Deen, S., Nolan, C., Spendlove, I., Ramage, J., Chan, S. and Durrant, L. G. (2016) Downregulation of the citrullinating enzyme Peptidyl-arginine deiminase type-2 in ovarian cancer indicates poor prognosis. Poster presented to: National Cancer Research Institute (NCRI) Cancer Conference, University of Birmingham, 2016-11-06 - 2016-11-09.
• Machado, L. (2016) Editorial Board Member. Biology Methods & Protocols. Oxford: Oxford University Press. 2396-8923.

2015

• Hargreaves, C. E., Iriyama, C., Rose-Zerilli, M. J. J., Nagelkerke, S. Q., Hussain, K., Ganderton , R., Lee, C., Machado, L., Hollox, E. J., Parker, H., Latham, K. V., Kuijpers, T. W., Potter, K. N., Coupland, S. E., Davies, A., Stackpole, M., Oates, M., Pettitt, A. R., Glennie, M. J., Cragg, M. S. and Strefford, J. C. (2015) Evaluation of high-throughput genomic assays for the Fc gamma receptor locus. PLoS ONE. 10(11) 1932-6203.
• Hargreaves, C. E., Iriyama, C., Rose-Zerilli, M. J. J., Nagelkerke, S. Q., Hussain, K., Ganderton, R., Lee, C., Machado, L., Hollox, E. J., Parker, H., Latham, K. V., Kuijpers, T. W., Potter, K. N., Coupland, S. E., Davies, A., Stackpole, M., Oates, M., Pettitt, A. R., Glennie, M. J., Cragg, M. S. and Strefford, J. C. (2015) Evaluation of high-throughput genomic assays for the Fc gamma receptor locus. PLoS ONE. 10(11), pp. 1-13. 1932-6203.
• Hargreaves, C. E., Rose-Zerilli, M. J. J., Machado, L., Iriyama, C., Hollox, E. J., Cragg, M. S. and Strefford, J. C. (2015) Fcγ receptors: genetic variation, function, and disease. Immunological Reviews. 268(1), pp. 6-24. 1600-065X.
• Durrant, L. G., Ottensmeier, C. H., Mulatero, C., Lorigan, P., Plummer , R., Cunnell, M., Metheringham, R., Brentville, V., Machado, L., Daniels , I., Hannaman, D. and Patel, P. M. (2015) A clinical trial of a DNA vaccine (SCIB1) that targets dendritic cells in vivo in fully resected melanoma patients; a vaccine to prevent disease recurrence? Poster presented to: 15th International Conference on Progress in Vaccination Against Cancer (PIVAC-15), Tübingen, Germany, 06-08 October 2015.
• Durrant, L. G., Ottensmeier, C. H., Mulatero, C., Lorigan, P., Plummer, R., Cunnell, M., Metheringham, R., Brentville, V., Machado, L., Daniels, I., Hannaman, D. and Patel, P. M. (2015) A clinical trial of a DNA vaccine (SCIB1) that targets dendritic cells in vivo in fully resected melanoma patients; a vaccine to prevent disease recurrence? Other presented to: 15th International Conference on Progress in Vaccination Against Cancer (PIVAC-15), Tübingen, Germany, 2015-10-06.
• Machado, L. (2015) Review Editor. Frontiers in Immunology. IUIS. 1664-3224.
• Zheng, Y., Parsonage, G., Zhuang, X., Machado, L., James, C., Salman, A., Searle, P., Hui, E. P., Chan, A. T. C. and Lee, S. P. (2015) Human Leukocyte Antigen (HLA) A*1101-restricted Epstein-Barr virus-specific T-cell receptor gene transfer to target Nasopharyngeal carcinoma. Cancer Immunology Research. 3(10), pp. 1138-1147. 2326-6066.
• Patel, P. M., Ottensmeier, C., Mulatero, C., Lorigan, P., Plummer, R., Hannaman, D., Cunnell, M., Metheringham, R. L., Brentville, V. A., Daniels, I., Machado, L. and Durrant, L. G. (2015) Abstract 9035: An adjuvant clinical trial of SCIB1, a DNA vaccine that targets dendritic cells in vivo, in fully resected melanoma patients. Journal of Clinical Oncology. 33(15 Sup) 0732-183X.
• Machado, L. and Ottolini, B. (2015) An evolutionary history of defensins: a role for copy number variation in maximizing host innate and adaptive immune responses. Frontiers in Immunology. 6(115) 1664-3224.
• Machado, L. and Ottolini, B. (2015) An evolutionary history of defensins: a role for copy number variation in maximizing host innate and adaptive immune responses. Frontiers in Immunology. 6(115) 1664-3224.
• Zheng, Y., Parsonage, G., Zhuang, X., Machado, L., James, C., Salman, A., Searle, P., Hui, E. P., Chan, A. T. C. and Lee, S. P. (2015) Human Leukocyte Antigen (HLA) A*1101-restricted Epstein-Barr virus-specific T-cell receptor gene transfer to target Nasopharyngeal carcinoma. Cancer Immunology Research. 3(10), pp. 1138-1146. 2326-6066.
• Haridan, U. S., Mokhtar, U., Machado, L., Abdul Aziz, A. T., Shueb, R. H., Zaid, M., Sim, B., Mustafa, M., Nik Yusof, N. K., Lee, C. K. C., Abu Bakar, S., AbuBakar, S., Hollox, E. J. and Boon Peng, H. (2015) A comparison of assays for accurate copy number measurement of the low-affinity Fc gamma receptor genes FCGR3A and FCGR3B. PLoS ONE. 10(1) 1932-6203.
• Haridan, U. S., Mokhtar, U., Machado, L., Abdul Aziz, A. T., Shueb, R. H., Zaid, M., Sim, B., Mustafa, M., Nik Yusof, N. K., Lee, C. K. C., Abu Bakar, S., AbuBakar, S., Hollox, E. J. and Boon Peng, H. (2015) A Comparison of Assays for Accurate Copy Number Measurement of the Low-Affinity Fc Gamma Receptor Genes FCGR3A and FCGR3B. PLoS ONE. 10(1), pp. 1-13. 1932-6203.

2014

• Hargreaves, C., Iriyama, C., Rose-Zerilli, M., Lee, C., Potter, K., Ganderton, R., Hussain, K., Machado, L., Hollox, E. J., Coupland, S., Stackpole, M., Oates, M., Pettitt, A. R., Cragg, M. and Strefford, J. (2014) Genomic dissection of the Fcγ receptor region in the context of monoclonal antibody therapy. Blood. 124(21), p. 2996. 0006-4971.
• Durrant, L. G., Ottensmeier, C., Lorigan, P., Mulatero, C., Plummer, R., Cunell, M., Metheringham, R. L., Brentville, V. A. and Machado, L. (2014) Abstract CT331: Phase I/II trial of a novel antibody DNA immunotherapy, targeting CD64, in the treatment of Melanoma. Cancer Research. 74(19 Sup) 0008-5472.
• Dupont, A., Mohamed, F., Salehen, N.'A., Glenn, S., Francescut, L., Adib, R., Byrne, S., Brewin, H., Elliott, I., Richards, L., Dimitrova, P., Schwaeble, W., Ivanovska, N., Kadioglu, A., Machado, L., Andrew, P. W. and Stover, C. (2014) Septicaemia models using Streptococcus pneumoniae and Listeria monocytogenes: understanding the role of complement properdin. Medical Microbiology and Immunology. 203(4), pp. 257-271. 0300-8584.
• Dupont, A., Mohamed, F., Salehen, N.'A., Glenn, S., Francescut, L., Adib, R., Byrne, S., Brewin, H., Elliott, I., Richards, L., Dimitrova, P., Schwaeble, W., Ivanovska, N., Kadioglu, A., Machado, L., Andrew, P. W. and Stover, C. (2014) Septicaemia models using Streptococcus pneumoniae and Listeria monocytogenes: understanding the role of complement properdin. Medical Microbiology and Immunology. 203(4), 257–271. 0300-8584.
• Patel, P. M., Durrant, L. G., Ottensmeier, C., Mulatero, C., Lorigan, P., Plummer, R., Cunnell, M., Metheringham, R. L., Brentville, V. A., Machado, L., Daniels, I. and Hannaman, D. (2014) Phase I trial of ImmunoBody in melanoma patients. Poster presented to: 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, McCormick Place, Chicago, Illinois, 30 May - 03 June 2014. (Unpublished)
• Durrant, L. G., Xue, L., Machado, L., Metheringham, R. L. and Brentville, V. A. (2014) DNA vaccines. In: Rees, R. C. (ed.) Tumor Immunology and Immunotherapy. Oxford: Oxford University Press. pp. 251-264.
• Machado, L., Moseley, P., Moss, R., Nolan, C., Rampage, J., Chan, S. and Durrant, L. G. (2014) High-mobility group protein 1 (HMGB1) is an independent predictor of poor survival in ovarian cancer. Poster presented to: National Cancer Research Institute (NCRI) Cancer Conference, Liverpool, UK, 02-05 November 2014. Also presented at: British Society for Immunology Annual Congress (BSI2014), Brighton, UK, 01-04 December 2014 (Unpublished)

2013

• Machado, L., Bowdrey, J., Ngaimisi, E., Habtewold, A., Minzi, O., Makonnen, E., Yimer, G., Amogne, W., Mugusi, S., Janabi, M., Aderaye, G., Mugusi, F., Viskaduraki, M., Aklillu, E. and Hollox, E. J. (2013) Copy number variation of Fc gamma receptor genes in HIV-infected and HIV-tuberculosis co-infected individuals in Sub-Saharan Africa. PLoS ONE. 8(11) 1932-6203.
• Machado, L., Bowdrey, J., Ngaimisi, E., Habtewold, A., Minzi, O., Makonnen, E., Yimer, G., Amogne, W., Mugusi, S., Janabi, M., Aderaye, G., Mugusi, F., Viskaduraki, M., Aklillu, E. and Hollox, E. J. (2013) Copy number variation of Fc gamma receptor genes in HIV-infected and HIV-tuberculosis co-infected individuals in Sub-Saharan Africa. PLoS ONE. 8(11) 1932-6203.
• Machado, L. (2013) Visiting Fellow. University of Leicester.

2012

• Hardwick, R. J., Amogne, W., Mugusi, S., Yimer, G., Ngaimisi, E., Habtewold, A., Minzi, O., Makonnen, E., Janabi, M., Machado, L., Viskaduraki, M., Mugusi, F., Aderaye, G., Lindquist, L., Hollox, E. J. and Aklillu, E. (2012) B-defensin genomic copy number is associated with HIV load and immune reconstitution in sub-Saharan Africans. The Journal of Infectious Diseases. 206(7), pp. 1012-1019. 1537-6613.
• Machado, L., Hardwick, R. J., Bowdrey, J., Bogle, H., Knowles, T., Sironi, M. and Hollox, E. J. (2012) Evolutionary history of copy-number-variable locus for the low-affinity Fcy receptor: mutation rate, autoimmune disease, and the legacy of helminth infection. The American Journal of Human Genetics. 90(6), pp. 973-985. 0002-9297.
• Machado, L., Hardwick, R. J., Bowdrey, J., Bogle, H., Knowles, T., Sironi, M. and Hollox, E. J. (2012) Evolutionary history of copy-number-variable locus for the low-affinity Fcy receptor: mutation rate, autoimmune disease, and the legacy of helminth infection. The American Journal of Human Genetics. 90(6), pp. 973-985. 0002-9297.
• Parsonage, G., Machado, L., Hui, J. W.-Y., McLarnon, A., Schmaler, T., Balasothy, M., To, K.-F., Vlantis, A. C., Hasselt, C. A. V., Lo, K.-W., Wong, W.-L., Hui, E. P., Cheung Chan, A. T. and Lee, S. P. (2012) CXCR6 and CCR5 localize T lymphocyte subsets in nasopharyngeal carcinoma. American Journal of Pathology. 180(3), pp. 1215-1222. 0002-9440.

2011

• Machado, L., Hardwick, R. J., Bogle, H., Bowdrey, J., Sironi, M. and Hollox, E. J. (2011) Evolutionary history of the low-affinity Fc gamma receptor copy number variable locus: diversity, disease and helminth infection. Poster presented to: Annual Congress of the British Society for Immunology, Liverpool, UK, 05-08 December 2011. (Unpublished)
• Hardwick, R. J., Amogne, W., Mugusi, S., Yimer, G., Ngaimisi, E., Habtewold, A., Minzi, O., Makonnen, E., Janabi, M., Machado, L., Mugusi, F., Aderaye, G., Lindquist, L., Hollox, E. J. and Aklillu, E. (2011) β-Defensin genomic copy number is associated with HIV viral load and immune reconstitution in sub-Saharan Africans. Poster presented to: Annual Congress of the British Society for Immunology, Liverpool, UK, 05-08 December 2011. (Unpublished)
• Hardwick, R. J., Machado, L., Zuccherato, L., Antolinos, S., Xue, Y., Shawa, N., Gilman, R., Cabrera, L., Berg, D., Tyler-Smith, C., Kelly, P., Tarazona-Santos, E. and Hollox, E. J. (2011) A worldwide analysis of beta-defensin copy number variation suggests recent selection of a high-expressing DEFB103 gene copy in East Asia. Human Mutation. 32(7), pp. 743-750. 1059-7794.

2010

• Zheng, Y., Machado, L., Johnson, B., James, C., Parsonage, G. and Lee, S. P. (2010) EBV-specific T cell receptor gene transfer to target nasopharyngeal carcinoma. Poster presented to: 14th Biennial Conference of the International Association for Research on Epstein-Barr Virus and Associated Diseases, University of Birmingham, 04-07 September 2010. (Unpublished)
• Parsonage, G., Machado, L., Hui, J. W.-Y., Schmaler, T. T., Balasothy, M., Van Hasselt, A., Vlantis, L., Hui, E. P., Chan, A. T. C., Lo, K.-W. and Lee, S. P. (2010) T cell homing to nasopharyngeal carcinoma. Poster presented to: 14th Biennial Conference of the International Association for Research on Epstein-Barr Virus and Associated Diseases, University of Birmingham, 04-07 September 2010. (Unpublished)

2009

• Russell, L., Capasso, M., Vater, I., Akasaka, T., Bernard, O., Calasanz, M. J., Chandrasekaran, T., Chapiro, E., Gesk, S., Griffiths, M., Guttery, D., Haferlach, C., Harder, L., Heidenreich, O., Irving, J., Kearney, L., Nguyen-Khac, F., Machado, L., Minto, L., Majid, A., Moorman, A., Morrison, H., Rand, V., Strefford, J., Schwab, C., Tonnies, H., Dyer, M., Siebert, R. and Harrison, C. (2009) Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood. 114(13), pp. 2688-2698. 0006-4971.
• Machado, L., Jarrett, R., Morgan, S., Murray, P., Hunter, B., Hamilton, E., Crocker, J., Thomas, W., Steven, N., Ismail, T., Chapman, A., Adams, D. H. and Lee, S. P. (2009) Expression and function of T cell homing molecules in Hodkins's lymphoma. Cancer Immunology, Immunotherapy. 58(1), pp. 85-94. 0340-7004.
• Zheng, Y., Machado, L., Johnson, B., James, C., Parsonage, G. and Lee, S. P. (2009) T cell receptor gene transfer to target the Epstein-Barr virus-associated malignancy nasopharyngeal carcinoma. Poster presented to: National Cancer Research Institute (NCRI) Cancer Conference, University of Birmingham, UK, 05-07 October 2009. (Unpublished)

2008

• Palendira, U., Chinn, R., Raza, W., Piper, K., Pratt, G., Machado, L., Bell, A., Khan, N., Hislop, A., Steyn, R., Rickinson, A., Buckley, C. and Moss, P. (2008) Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow. Blood. 112(8), pp. 3293-3302. 0006-4971.
• Baumforth, K. R. N., Birgersdotter, A., Reynolds, G. M., Wei, W., Kapatai, G., Flavell, J., Kalk, E., Piper, K., Lee, S. P., Machado, L., Hadley, K., Sundblad, A., Sjoberg, J., Bjorkholm, M., Porwit, A., Yap, L.-F., Teo, S., Grundy, R., Young, L. S., Ernberg, I., Woodman, C. and Murray, P. (2008) Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's Lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells. The American Journal of Pathology. 173(1), pp. 195-204. 0002-9440.
• Russell, L., Capasso, M., Vater, I., Moorman, A., Akasaka, T., Harder, L., Heidenreich, O., Machado, L., Gest, S., Strefford, J., Chandrasekaran, T., Tonnies, H., Majid, A., Bernard, O., Dyer, M., Siebert, R. and Harrison, C. (2008) IGH@ translocations involving the pseudoautosomal region 1 (PAR1) of both sex chromosomes deregulate the cytokine receptor-like factor 2 (CRLF2) gene in B cell precursor acute lymphoblastic leukemia (BCP-ALL). Paper presented to: 50th American Society of Hematology (ASH) Annual Meeting and Exposition, San Francisco, California, 06-09 December 2008. (Unpublished)

2007

• Machado, L., Jarrett, R., Morgan, S., Murray, P., Hunter, B., Crocker, J., Thomas, W., Steven, N., Ismail, T., Chapman, A., Adams, D. and Lee, S. P. (2007) Molecular mechanisms for T cell recruitment to Hodgkin's lymphoma. Poster presented to: Keystone Symposia on Molecular and Cellular Biology: The Potent New Anti-Tumor Immunotherapies, Banff, Alberta, Canada, 28 March - 02 April 2007. (Unpublished)
• Machado, L., Schmaler, T. T., Balasothy, M., Morgan, S., Larsen, M., Hislop, A., Murray, P., Mack, M., Adams, D., Van Hasselt, A., Hui, E. P., Chan, A. T. C. and Lee, S. P. (2007) CXCR6 and CCR5 mediate recruitment of CD4 and CD8 T lymphocytes to nasopharyngeal carcinoma. Poster presented to: Cancer Research UK Midlands Regional Meeting, Birmingham, UK, April 2007. (Unpublished)

2006

• Hamilton, E., Machado, L., Reynolds, G. M., Taniere, P., Lee, S. P., Steven, N. and Ismail, T. (2006) Biomarkers of the immune response in primary colorectal cancer. Poster presented to: Annual Meeting of the British Society of Gastroenterology, Surgical Section in Association with the Association of Coloproctology (ACPGBI) and IBD Section Joint Symposium, Birmingham, UK, 20-23 March 2006. (Unpublished)

2005

• Lee, S. P., Green, A. M., Machado, L., Patel, P., Thomas, W., Goodyear, O., Briggs, D., McDonald, D., Marsden, J. and Steven, N. (2005) Infusing advanced cancer patients with tumour antigen-specific CD4+ and CD8+ T cell clones. Poster presented to: Annual Congress of the British Society for Immunology, Harrogate, UK, 06-09 December 2005. (Unpublished)

2003

• Lee, S. P., Hewitt, A., Thomas, W., Machado, L., Goodyear, O., Marsden, J., Van der, B., Briggs, D. and Steven, N. (2003) Generating cancer/testis antigen- and Epstein-Barr virus-specific T cell clones for adoptive immunotherapy. Poster presented to: Keystone Symposia on Molecular and Cellular Biology: Basic Aspects of Tumour Immunology, Colorado, USA, 2003. (Unpublished)